Kapiva builds science-backed ayurvedic brand
By Abha Lohia · Editor ·
Kapiva: revenue and funding and every story →
Founded 2016
- Kapiva sells ayurvedic supplements for wellness, diabetes, heart health and gym nutrition
- Founded in 2016, it raised nearly $120 Mn from investors including Fireside Ventures and OrbiMed
- It focuses on clinical trials and R&D to attract younger consumers wary of heavy metals
What happened
- Kapiva was launched as a D2C ayurvedic brand in 2016, with its first products rolled out in 2017.
- It initially sold supplements for diabetes and heart ailments through contract manufacturing, later moving to own formulations.
- The company opened ayurvedic clinics in Mumbai but shut them down by 2018 due to high costs and limited reach.
- It pivoted to an online-first D2C model, selling through its own website, Amazon and Flipkart.
- From 2019 to 2021, it hired a dedicated R&D head and built a team of 15-20 researchers.
- It began clinical trials including in vitro and in vivo studies, and products now undergo up to 10 levels of testing.
- In 2022, it raised a $28 Mn Series C from OrbiMed, which brought global healthcare expertise and DNA fingerprinting.
- Last year, it raised a $60 Mn Series D from 360 One Asset and Vertex Ventures to bolster R&D, manufacturing and marketing.
Why it matters
- India's ayurveda market is one-fourth of the $40 Bn pharma market, while China's traditional medicine market is a $50 Bn opportunity in an $80 Bn pharma market.
- India's ayurveda lacks rigorous evidence-based scientific research, and heavy metals in ayurvedic drugs exceeding safe limits put off younger consumers.
- Younger consumers prefer quick relief, while ayurveda demands time and patience.
- India's D2C market is a $100 Bn opportunity with over 50,000 digital-first brands, and India has 427 Mn ecommerce users.
The business
- Kapiva sells ayurvedic supplements across wellness, diabetes care, heart health and gym nutrition.
- It sells through its own website, Amazon and Flipkart.
- Products undergo up to 10 levels of testing, and clinical trials and certifications are mentioned on packaging.
- Revenue in FY25 was INR 342 Cr, and it targets INR 600 Cr in the current fiscal.
- Since FY23, revenues have nearly doubled every year, driven by repeat consumption.
- Losses are narrowing to single digits.
The founders
AS
Ameve Sharma
Founder- Carries the legacy of Baidyanath in his genes.
- A management graduate from France.
- Spent five years in the family business, then joined McKinsey as a consultant.
- Spotted a dearth of modern science-backed ayurvedic brands.
SB
Shrey Badhani
Co-founder- Former associate at Bain & Company with exposure to private equity and startups.
Who put in money
- Fireside Ventures existing — First institutional investor in Kapiva.
- 3one4 Capital existing
- 360 One Asset existing — Led the Series D round last year.
- Vertex Ventures existing — Co-led the Series D round last year.
- OrbiMed existing — New York-based healthcare-focused investor; led the Series C round in 2022.
In numbers
INR 342 CrRevenue · FY25
INR 600 CrRevenue target · Current fiscal
nearly $120 MnTotal raised · As of 2026
INR 4.4 CrAngel round
$28 MnSeries C · 2022
$60 MnSeries D · Last year
What happens next
- Bolster R&D, manufacturing and marketing with Series D funds.
Earlier rounds
- Angel · INR 4.4 Cr
- 2022 · Series C · $28 Mn · led by OrbiMed
- Last year · Series D · $60 Mn · led by 360 One Asset and Vertex Ventures
Words to know
- D2C
- Direct-to-consumer, a business model where a brand sells its products directly to customers without intermediaries like wholesalers or retailers.
- Ayurveda
- An ancient Indian system of medicine that uses natural herbs and treatments to balance the body, mind and spirit.
- Clinical trials
- Scientific studies that test the safety and effectiveness of a product on humans or in labs before it is sold.
- DNA fingerprinting
- A technique used to identify the genetic makeup of plants or herbs to ensure their authenticity and purity in products.
The numbers around it
Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →
Read next
LaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugarFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Kapiva → · All startup news on 31 January 2026 →
Is this Kapiva? Get your “Featured on StopDown” badge →